Markets /Healthcare /ERYP ERYTECH Pharma S.A. ERYP Full chart Compare Add to watchlist Set alert Price alert · ERYP Alert when the price is Price abovePrice below Price level Set alert All alert types 0.78 +0.78 Day range unavailable 52-week range unavailable Overview Chart Financials FinancialsValuation & healthEarnings EarningsDividends & splitsAnalysts News Ownership Options More ComparisonSignalsTrend ScoreDiscussionNotesPositionsAlerts FinancialsValuation & health Revenue history · Free cash flow history OverviewIncome statementBalance sheetCash flow Revenue & Expenses AnnualQuarterly FY 2019FY 2018 Other Income → Expenses: $51.78MExpenses → Gross Loss: $48.83MExpenses → Selling, General & Admin: $17.16MExpenses → Research & Development: $52.19MExpenses → Interest Expense: $1.53MOther Operating Income → Expenses: $5.28MIncome Tax Benefit → Expenses: $1.00KNet Loss → Expenses: $62.66MRevenue → Cost of Revenue: $3.36MOther Income$51.78MOther Operating Income$5.28MIncome Tax Benefit$1.00KNet Loss$62.66MCost of Revenue$52.19MExpenses$119.72MGross Loss$48.83MSelling, General & Admin$17.16MResearch & Development$52.19MInterest Expense$1.53MRevenue$3.36M No annual statement lines ERYP has no annual lines for this statement.
